phase iii trial - Robuta Search

https://uk.marketscreener.com/news/astrazeneca-plc-announces-positive-high-level-results-from-the-emerald-3-phase-iii-trial-ce7e51dcde80f421 Astrazeneca plc Announces Positive High-Level Results from the Emerald-3 Phase III Trial |... Apr 2, 2026 - AstraZeneca PLC announced that Imjudo is a human monoclonal antibody that targets the activity of cytotoxic T-lymphocyte-associated protein 4 . Imjudo blocks... phase iii trial astrazeneca plc high level results from announces https://www.biocentury.com/article/58763/nevirapine-started-a-phase-iii-trial BioCentury - Nevirapine: Started a Phase III trial The international trial will evaluate patients for 18-24 months, and will include only patients who are non-nucleoside reverse transcriptor inhibitor-naive... phase iii trial started https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2019-1002.html A Randomized, Double Blind, Placebo-Controlled Multicenter Phase III Trial of Alpha 1- Antitrypsin... Study CSL964\_5001 will investigate the efficacy of AAT with corticosteroids compared with corticosteroids alone as first line therapy for patients with... phase iii trial double blind placebo controlled alpha https://eprints.soton.ac.uk/430268/ Randomized phase III trial of ibrutinib and rituximab plus cyclophosphamide, doxorubicin,... phase iii trial ibrutinib plus cyclophosphamide doxorubicin https://www.biospace.com/inflarx-presents-new-analysis-of-panamo-phase-iii-trial-in-severe-covid-19-at-ats-2024-showing-potential-synergy-with-vilobelimab-when-used-in-combination-with-other-immunomodulators InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing... May 21, 2024 - InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced data presented... phase iii trial presents new analysis severe https://www.clinicaltrialsarena.com/news/entasis-acinetobacter-infections-trial/ Entasis begins Phase III trial to address Acinetobacter infections Jul 12, 2022 - Entasis Therapeutics has initiated the ATTACK trial of ETX2514SUL to treat pneumonia and bloodstream infections by Acinetobacter baumannii. phase iii trial begins address infections https://ecancer.org/en/video/6549-phase-iii-trial-data-supports-current-standard-12-month-adjuvant-trastuzumab-for-her2-positive-breast-cancer Phase III trial data supports current standard 12-month adjuvant trastuzumab for HER2-positive... Prof Joensuu speaks at a SABCS 2017 press session about data from the phase III Synergism or Long Duration (SOLD) clinical trial. Disease- phase iii trial data supports current standard https://nordiclifescience.org/lidds-licensee-prepares-for-phase-iii-trial-in-china/ LIDDS licensee prepares for phase III trial in China - NLS Nov 8, 2019 - LIDDS licensee Jiangxi Puheng Pharma has after reviewing the preliminary results in LPC-004 decided to move ahead and has initiated discussions with Chinese... phase iii trial in china licensee prepares nls https://salesandmarketingnetwork.com/news_release_bs.html?pipe=0000ac177000191&ID=2025246&key=hydroxyurea News for Medical Sales Reps: Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of... phase iii trial for medical sales reps news eisai https://biopharmaboardroom.com/news/14/3719/roche-and-alnylam-target-uncontrolled-hypertension-with-zenith-phase-iii-trial.html Roche and Alnylam Target Uncontrolled Hypertension with ZENITH Phase III Trial phase iii trial roche target uncontrolled hypertension https://christie.openrepository.com/entities/publication/aede0a22-297b-4111-b430-fdf1a54c6cc6 Phase III trial comparing supportive care alone with supportive care with oral topotecan in... PURPOSE: For patients with small-cell lung cancer (SCLC), further chemotherapy is routinely considered at relapse after first-line therapy. However, proof of... phase iii trial supportive care comparing alone oral https://pharmacyindia.co.in/faricimab-an-eye-medicine-from-roche-should-be-approved-with-a-local-phase-iii-trial-waiver-according-to-the-sec/ Faricimab, an eye medicine from Roche, should be approved with a local phase III trial waiver,... Mar 4, 2023 - Faricimab intravitreal injection, manufactured by Swiss multinational pharmaceutical company Roche, has been approved for import and marketing in India, with phase iii trial eye medicine roche approved https://biopharmaapac.com/news/80/6001/akeso-begins-phase-iii-trial-of-ivonescimab-for-first-line-treatment-of-advanced-triple-negative-breast-cancer.html Akeso Begins Phase III Trial of Ivonescimab for First-Line Treatment of Advanced Triple-Negative... Triple-Negative Breast Cancer phase iii trial first line triple negative akeso begins https://www.news-medical.net/news/2009/02/18/45982.aspx GlaxoSmithKline starts phase III trial of Syncria (albiglutide) type 2 diabetes medication Jun 18, 2019 - GlaxoSmithKline has announced initiation and dosing of the first patient of the Phase III clinical trial programme to evaluate the efficacy, safety and... phase iii trial diabetes medication glaxosmithkline starts type https://research.unipd.it/handle/11577/3410516 Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer:... phase iii trial biomarker analysis first line ovarian cancer treatment https://www.oncolink.org/oncolink-library/journal-scans/endometrial-and-uterine-cancers/randomized-phase-iii-trial-of-pelvic-radiotherapy-versus-cisplatin-based-combined-chemotherapy-in-patients-with-intermediate-and-high-risk-endometrial-cancer-a-japanese-gynecologic-oncology-group-study Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in... OncoLink, the Web's first cancer resource,provides comprehensive information on coping with cancer, cancer treatments, cancer research advances, continuing... phase iii trial pelvic radiotherapy versus cisplatin https://www.avera.org/research-and-clinical-trials/clinical-trials/detail/?id=252 A092205_HNSCC: Randomized Phase III Trial of Pembrolizumab vs. Pembrolizumab/Cetuximab in Recurrent... PhIII Trial of Pembro vs Pembro/Cetux in Recurrent or Metastatic HN Squamous Cell Carcinoma with Platinum Refractory Disease phase iii trial pembrolizumab vs recurrent https://boa.unimib.it/handle/10281/403095 Randomized phase III trial on niraparib-TSR-042 (dostarlimab) versus physician's choice... phase iii trial tsr versus physician choice https://pharmadevicenews.com/medipost-raises-140m-to-fund-u-s-phase-iii-trial-of-stem-cell-therapy-for-knee-osteoarthritis/ Medipost raises $140m to fund U.S. Phase III trial of stem cell therapy for knee osteoarthritis -... Jan 10, 2026 - Medipost secures $140M to fund a pivotal U.S. Phase III trial in osteoarthritis. See how this could reshape the future of scalable stem cell therapies. phase iii trial stem cell therapy knee osteoarthritis fund https://www.chemdiv.com/company/media/pharma-news/2026/roche-s-phase-iii-trial-of-fenebrutinib-in-rms-meets-primary-endpoint/ Roche's Phase III Trial of Fenebrutinib in RMS Meets Primary Endpoint Roche reports its Phase III FENhance 1 trial for fenebrutinib in relapsing multiple sclerosis met its primary endpoint, reducing... phase iii trial primary endpoint roche fenebrutinib rms https://www.expresspharma.in/novartiss-tislelizumab-phase-iii-trial-data-shows-survival-results-in-esophageal-cancer/ Novartis's tislelizumab phase-III trial data shows survival results in esophageal cancer - Express... Jul 5, 2022 - First-line tislelizumab plus chemotherapy showed median Overall Survival (OS) of 17.2 months versus 10.6 months for chemotherapy and reduced risk of death by... phase iii trial data shows esophageal cancer novartis survival https://researchers.evms.edu/display/pub26597368 Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion... phase iii trial results of controlled hepatic perfusion https://adisinsight.springer.com/trials/700361326?error=cookies_not_supported&code=a7ad99f1-0e38-4c59-932f-9df5717d36e8 Randomized Phase III Trial of Chemotherapy vs. Pembrolizumab Plus Chemotherapy for... This phase III trial compares chemotherapy versus an immune checkpoint inhibitor drug called pembrolizumab plus chemotherapy in treating patients with classical phase iii trial chemotherapy vs pembrolizumab plus https://www.cancernetwork.com/view/children-s-oncology-group-aall1331-phase-iii-trial-of-blinatumomab-in-children-adolescents-and-young-adults-with-low-risk-b-cell-all-in-first-relapse Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and... May 16, 2026 - Results from the phase 3 COG ALL1331 trial found the use of blinatumomab for pediatric patients with B-cell acute lymphoblastic leukemia improved efficacy. phase iii trial children oncology group adolescents https://sms.carm.es/ricsmur/handle/123456789/18937?show=full Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With... phase iii trial in patients adjuvant standard neo https://medicaex.com/prnewswire/akesos-cadonilimab-pd-1-ctla-4-phase-iii-trial-meets-primary-endpoint-at-interim-analysis-demonstrating-strong-overall-survival-benefit-as-first-line-treatment-in-all-comer-patients-with-gastric/ Akeso's Cadonilimab (PD-1/CTLA-4) Phase III Trial Meets Primary Endpoint at Interim Analysis... Nov 13, 2023 - HONG KONG, Nov. 7, 2023 /PRNewswire/ -- Akeso (9926.HK) announced positive results from an interim analysis of AK104-302 study, a randomized, double-blind,... phase iii trial primary endpoint akeso pd meets https://pubmed.ncbi.nlm.nih.gov/22234626/ Results of the GYNECO 02 study, an FNCLCC phase III trial comparing hysterectomy with no... Results of the current trial seem to suggest that completion HT had no therapeutic impact in patients with clinical and radiological complete response after... phase iii trial results of study comparing hysterectomy https://pure.psu.edu/en/publications/randomized-phase-iii-trial-of-cisplatin-with-or-without-topotecan/ Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine... phase iii trial cisplatin without carcinoma uterine https://jnccn360.org/mm/videos/new-data-on-combination-regimen-from-phase-iii-trial-in-multiple-myeloma/ JNCCN 360 - MM - Prashant Kapoor, MD, on New Data on Combination Regimen From Phase III Trial in... phase iii trial new data jnccn mm prashant https://www.med-chemist.com/2015/09/medday-announces-additional-positive.html Med-Chemist: MedDay announces additional positive results from MD1003 Phase III trial in patients... phase iii trial positive results in patients med chemist https://pure.eur.nl/en/publications/final-results-of-the-eortc-18871dkg-80-1-randomised-phase-iii-tri/ Final results of the EORTC 18871/DKG 80-1 randomised phase III trial. rIFN-alpha2b versus... phase iii trial results of final eortc dkg https://unifind.uniss.it/resource/item/53125?language=en-US Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted... Unifind is a portal where you can discover the expertise within a university by searching among experts, courses, professions, people, publications, and... phase iii trial gastric cancer adjuvant chemotherapy completely https://pancan.org/press-releases/pancan-statement-on-positive-overall-survival-results-from-revolution-medicines-phase-iii-trial/ PanCAN Statement on Positive Overall Survival Results from Revolution Medicines Phase III Trial -... Apr 14, 2026 - The Pancreatic Cancer Action Network (PanCAN), the leading organization dedicated to advancing progress against pancreatic cancer, released a statement today... phase iii trial results from revolution medicines statement positive https://www.pharmaceutical-business-review.com/news/am-pharma-covid-19/ AM-Pharma enrols first patients in Covid-19 phase III trial Jan 8, 2021 - AM-Pharma has recruited first patients with Covid-19 infection and sepsis-associated acute kidney injury in an exploratory cohort of its phase III REVIVAL... phase iii trial pharma first patients covid https://www.clinicalleader.com/doc/full-service-client-support-for-a-late-clinical-stage-oncology-biotech-0001 Rescuing A Global Full-Service Phase III Trial For A Late-Stage Oncology Biotech This case underscores the expertise employed in a comprehensive strategy and set of services that were used to salvage a Phase III clinical trial for ovarian... phase iii trial full service late stage global oncology https://www.epistemonikos.org/en/documents/175a9799a644c7c0a33b45fa4907c8032df6490d A Phase III Trial of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With... phase iii trial in patients plus versus alone https://app.quri.ai/trials/NCT07553351/gb06-phase-iii-trial-for-pediatric-growth-hormone-deficiency GB06 Phase III Trial for Pediatric Growth Hormone Deficiency (NCTNCT07553351) - Patient Guide &... Connect with this clinical trial through Quri.ai's free matching service. GB06 Phase III Trial for Pediatric Growth Hormone Deficiency (NCTNCT07553351). We'll... phase iii trial growth hormone deficiency patient guide pediatric https://www.ibsgranada.es/en/ensayos-clinicos/ensayo-abierto-multicentrico-aleatorizado-y-pragmatico-de-fase-iii-para-evaluar-la-eficacia-y-seguridad-de-diferentes-duraciones-de-tratamiento-antimicrobiano-de-infecciones-asociadas-al-material-de-o/ Open-label, multicenter, randomized, pragmatic phase III trial to evaluate the efficacy and safety... ibs.GRANADA is located in the framework of collaboration between the University of Granada and the University Hospitals of Granada, centers with a high level... phase iii trial open label pragmatic evaluate https://profiles.ouhsc.edu/display/306637 Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only... phase iii trial tamoxifen versus thalidomide women https://www.mda.org/science/professional-medical-education/industry-update-webinars/2024/novel-approaches-in-the-clinical-management-of-mg-batoclimab-in-a-phase-iii-trial-using-induction Novel Approaches in the Clinical Management of MG: Batoclimab in a Phase III Trial Using... May 6, 2024 - MDA is the #1 health nonprofit advancing research, care and advocacy for people living with muscular dystrophy, ALS, and related neuromuscular diseases. phase iii trial clinical management novel approaches mg https://smallcaps.com.au/article/invex-therapeutics-fda-meeting-phase-iii-trial-presendin-treatment-idiopathic-intracranial-hypertension Invex Therapeutics granted FDA meeting to advance Presendin phase III trial for treating idiopathic... Apr 22, 2021 - Clinical-stage biopharmaceutical company Invex Therapeutics (ASX: IXC) has been granted a meeting with the US Food and Drug Administration to discuss the... phase iii trial invex therapeutics granted fda meeting https://flcube.com/?p=16116 Pfizer Launches Phase III Trial for Quadrivalent Influenza modRNA Vaccine in Argentina - Insight,... Dec 1, 2024 - Global pharmaceutical giant Pfizer (NYSE: PFE) has commenced recruitment in Argentina for a Phase III clinical trial evaluating the efficacy of its... phase iii trial pfizer launches influenza modrna https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-results-from-dreamm-7-head-to-head-phase-iii-trial-for-blenrep/ GSK announces positive results from DREAMM-7 head-to-head phase III trial for Blenrep in... Blenrep plus BorDex showed statistically significant progression-free survival (PFS) benefit versus daratumumab plus BorDex. phase iii trial positive results gsk announces dreamm https://e-crt.org/journal/view.php?viewtype=pubreader&number=2628 An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of... phase iii trial open label parallel evaluating https://health.economictimes.indiatimes.com/news/pharma/bharat-biotech-has-submitted-covaxins-phase-iii-trial-data-to-dcgi-govt-sources/83734973 Bharat Biotech has submitted Covaxin's Phase III trial data to DCGI: Govt sources, ETHealthworld Drugs Controller General Of India: Bharat Biotech's Covaxin is one of the three vaccines which are currently being used in India. The phase III data of its... phase iii trial bharat biotech submitted data